Sign in
Active, not recruitingNo phase

Multiomics Profiling of CSF in Cardiac Arrest Survivors

Key facts

Who runs it
Chungnam National University Hospital
Where
South Korea1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
15 people enrolled
Started
22 Jul 2025
Expected to end
31 Mar 2027
Type of study
Observational, 2 groups
Record updated
10 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Age ≥ 18 years old
  • Out-of-hospital cardiac arrest (OHCA)
  • Patients who have received post-resuscitation care including temperature control due to unconsciousness (Glasgow Coma Score < 8) after sustained ROSC
  • Patients who consented to the placement of lumbar catheter for storing cerebrospinal fluid and blood samples in a human biobank

Who cannot take part

  • Patients who have undergone extracorporeal circulatory membrane oxygenation therapy
  • Patients diagnosed with a central nervous system-related disease before cardiac arrest
  • Patients who died within 24 hours from post-resuscitation care

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to identify further pathophysiologic mechanism of secondary brain injury following cardiac arrest by using serial multiomics profiling of serum and cerebrospinal fluid (CSF) samples. The main question it aims to answer is:

Read full original descriptionShow less

A. The main question it aims to answer is: What are the dynamic molecular changes in serum and CSF that reflect the pathophysiological mechanisms of secondary brain injury after cardiac arrest? B. What are the differences in serum and CSF multiomic signatures between varying severities of cardiac arrest, and how are these differences associated with the underlying pathophysiological mechanisms of secondary brain injury?

Serum and CSF samples that have already been prospectively collected from participants and stored in the BioBank will be used for this analysis.

The 2 groups in the trial

  • good neurologic outcome

    Cerebral Performance Category (CPC) : 1 or 2

  • poor neurologic outcome

    Cerebral Performance Category (CPC) : 3 to 5

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Serial Multiomics Profiling Using Serum and Cerebrospinal Fluid Samples Following Out-of-hospital Cardiac Arrest: a Prospective Observational Study
Record updated
10 September 2026